A Study to Evaluate Liver Tumors with Ultrasound Microvessel Imaging and Shear Wave Elastography

Overview

About this study

The purpose of this study is to investigate the value of ultrasound imaging of tumor microvasculature and stiffness as new biomarkers for evaluation of liver tumor.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Male and female patients with liver cancers.
Undergoing medical therapy.
Age 18 or greater.
Body mass index (BMI) below 40.

Exclusion Criteria:

Patients with unreliable ultrasound images due to conditions such as fatty liver or poor ultrasound imaging window.
Adults lacking capacity to consent.
Vulnerable subjects such as prisoners, pregnant women, nursing mothers, patients with known or suspected right-to-left, bi-directional, or transient right-to-left cardiac shunts.
Patients with history of hypersensitivity allergic reactions to ultrasound contrast agents.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Shigao Chen, Ph.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Shigao Chen, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials